Imidin (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective α‑adrenergic agonist that binds to α‑1 and α‑2 receptors on the smooth muscle of nasal mucosal blood vessels. Activation causes vasoconstriction, which decreases blood flow, reduces edema, and opens the nasal airway. The effect is localized, with minimal systemic absorption when used as directed.

The specific dose of Imidin is determined by the prescribing healthcare professional based on the patient’s age, condition, and product formulation. Typically, a few sprays per nostril are administered, not exceeding the maximum daily frequency recommended on the label. Users should follow the instructions provided with the product or by their clinician.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. It is classified as a category that should be used only if the potential benefit justifies the potential risk to the fetus or infant. Pregnant or nursing women should consult their healthcare provider before using Imidin.

To place an order, submit an enquiry on the Imidin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then provides pricing, availability, shipping details and any necessary import documentation.

Imidin’s active ingredient, Xylometazoline Hydrochloride, belongs to the imidazoline class, which provides rapid vasoconstriction of nasal vessels. Compared with phenylephrine‑based sprays, Xylometazoline often offers a longer duration of action and may cause less systemic stimulation. However, all topical decongestants share a risk of rebound congestion if used beyond the recommended period.

Imidin should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed when not in use. Do not freeze the product, and keep it out of reach of children.

Imidin is applied intranasally. The user tilts the head slightly forward, inserts the spray tip into one nostril, and depresses the pump to deliver the recommended number of sprays. The same procedure is repeated in the other nostril if required. The spray should be used only as directed on the label or by a healthcare professional.

Although uncommon, serious adverse reactions can occur, including severe nasal bleeding, high blood pressure, rapid heart rate, and allergic reactions such as rash, itching or swelling of the face and throat. If any of these symptoms develop, use should be stopped immediately and medical attention sought. Prolonged use beyond three to five days may also lead to rebound congestion.

Imidin should not be used by individuals who are hypersensitive to Xylometazoline Hydrochloride or any other component of the formulation. It is also contraindicated in patients with severe hypertension, coronary artery disease, or those taking monoamine oxidase inhibitors. Children under the age specified on the product label should not use the spray unless directed by a pediatrician.